Skip to main content
Equibles

US BANCORP \DE\

Bank

Position in SPRO — Spero Therapeutics, Inc.

CIK 36104 MINNEAPOLIS, MN
Back to SPRO Full portfolio

Position in SPRO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$333
-$20 QoQ
Shares Held
151
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 59 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in SPRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $83,094,208 across 214 Biotechnology names. SPRO ranks #200 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
 66,580 $16,296,786
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 32,020 $15,905,293
3 TECH
BIO-TECHNE Corp
 137,966 $9,747,297
4 REGN
Regeneron Pharmaceuticals, Inc.
 5,330 $3,323,466
5 ARGX
Argenx SE
 3,495 $3,242,555
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 38,226 $3,115,799
7 JAZZ
Jazz Pharmaceuticals plc
 10,103 $2,434,518
8 GMAB
Genmab A/S
 88,420 $2,428,896

All Filings in SPRO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $333 151
2026-03-31 $353 151
2025-12-31 $351 151
2025-09-30 $283 151
2025-06-30 $437 151
2025-03-31 $108 151
2024-12-31 $5,305 5,151
2024-09-30 $202 151
2024-06-30 $196 151
2024-03-31 $259 151
2023-12-31 $221 151
2023-09-30 $182 151
2023-06-30 $218 151
2023-03-31 $218 151
2022-12-31 $261 151
2022-09-30 $302 151
2022-06-30 $111 151
2022-03-31 $10,013 1,151
2021-12-31 $18,427 1,151
2021-09-30 $18,410 1,000
2021-06-30 $41,880 3,000
2021-03-31 $44,160 3,000
2020-12-31 $58,170 3,000
2020-09-30 $33,480 3,000
2020-06-30 $13,530 1,000
2020-03-31 $4,040 500